Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,longTermDebt,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,otherCashflowsFromInvestingActivities,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,currency,priceHint,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,maxAge,address1,fax,industry,address2
t0,GBLP,7867364.0,0,198466,,-87966,1211257,-91443,358372,535053,-21785,-21785,,-66181,,,,0,728195,749980,193142,-66181,,-87966,-91443,103125.0,11374300.0,4381458.0,7970489.0,1201769.0,13563204.0,2325.0,64570.0,-4328160.0,922024.0,437684.0,5436580.0,4381458.0,2624400.0,922024.0,4883626.0,8138769.0,1609547.0,1028072.0,555289.0,,79348.0,-45567.0,-283330.0,-283330.0,235384.0,-30900.0,125691.0,172306.0,123873.0,-166386.0,21103.0,3477.0,-45567.0,,,3757311.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.2591 - 0.2591,0.2591,0.0,0.0,0,0,finmb_20442050,Other OTC,"Global Pharmatech, Inc.",USD,1221,0,0.20899999,4.1716566,0.0501 - 0.4,-0.14090002,-0.35225004,0.0501,0.4,-0.096,USD,4,0.343,0.2363689,0.022731096,0.09616788,0.15947415,0.09962584,0.6247147,1835521,0.75539356,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.2591,1627673631,0.0,0.1732,0.2591,0.2591,14200,GLOBAL PHARMATECH INC,us_market,POST,-4.51,,,0.4,0.0501,0.2364,0.1595,1.22k,,,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2007","Jun 29, 2008",-70.45%,-72.55%,-10.39%,-22.59%,3.18M,0.14,21.50%,1.32M,-1.81M,-2.24M,-0.0960,,5.44M,0.23,2.62M,28.58,1.86,0.34,170.85k,325.78k,Value,130 012,Healthcare,217,"Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.",Changchun,86 431 8554 1826,1199059200,China,86400,509 Maoxiang Street,86 431 8554 1869,Drug Manufacturers—Specialty & Generic,High-Tech Industrial Development Zone
t-1,GBLP,7855351.0,0,196268,,-190961,1177479,-213650,347820,322403,-221685,-221685,,-63029,,,,0,702422,924107,380019,30724,,-190961,-213650,117666.0,11374300.0,4400202.0,7973017.0,1088067.0,13550698.0,2325.0,78480.0,-4236167.0,832559.0,430211.0,5467480.0,4400202.0,2564460.0,832559.0,4830143.0,8172678.0,1790263.0,836455.0,462735.0,,-40567.0,-32432.0,-283330.0,-283330.0,-69302.0,48313.0,216951.0,-136206.0,120136.0,55361.0,53426.0,22690.0,-32432.0,,,3772476.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.2591 - 0.2591,0.2591,0.0,0.0,0,0,finmb_20442050,Other OTC,"Global Pharmatech, Inc.",USD,1221,0,0.20899999,4.1716566,0.0501 - 0.4,-0.14090002,-0.35225004,0.0501,0.4,-0.096,USD,4,0.343,0.2363689,0.022731096,0.09616788,0.15947415,0.09962584,0.6247147,1835521,0.75539356,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.2591,1627673631,0.0,0.1732,0.2591,0.2591,14200,GLOBAL PHARMATECH INC,us_market,POST,-4.51,,,0.4,0.0501,0.2364,0.1595,1.22k,,,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2007","Jun 29, 2008",-70.45%,-72.55%,-10.39%,-22.59%,3.18M,0.14,21.50%,1.32M,-1.81M,-2.24M,-0.0960,,5.44M,0.23,2.62M,28.58,1.86,0.34,170.85k,325.78k,Value,130 012,Healthcare,217,"Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.",Changchun,86 431 8554 1826,1199059200,China,86400,509 Maoxiang Street,86 431 8554 1869,Drug Manufacturers—Specialty & Generic,High-Tech Industrial Development Zone
t-2,GBLP,7907819.0,0,158764,,-1580329,1104145,-1503662,652240,382552,-1730476,-1730476,,-53254,,,,0,1227948,2958424,845396,150147,,-1580329,-1503662,129237.0,11374300.0,4191791.0,8037056.0,968491.0,13332992.0,2325.0,46527.0,-4022517.0,682948.0,415816.0,5419167.0,4191791.0,2464200.0,682948.0,4708689.0,8079250.0,1743276.0,858025.0,485300.0,,119857.0,-92887.0,-283330.0,-283330.0,494661.0,243998.0,64148.0,272737.0,151017.0,312756.0,-596665.0,1225357.0,-31482.0,-6692.0,,3887459.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.2591 - 0.2591,0.2591,0.0,0.0,0,0,finmb_20442050,Other OTC,"Global Pharmatech, Inc.",USD,1221,0,0.20899999,4.1716566,0.0501 - 0.4,-0.14090002,-0.35225004,0.0501,0.4,-0.096,USD,4,0.343,0.2363689,0.022731096,0.09616788,0.15947415,0.09962584,0.6247147,1835521,0.75539356,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.2591,1627673631,0.0,0.1732,0.2591,0.2591,14200,GLOBAL PHARMATECH INC,us_market,POST,-4.51,,,0.4,0.0501,0.2364,0.1595,1.22k,,,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2007","Jun 29, 2008",-70.45%,-72.55%,-10.39%,-22.59%,3.18M,0.14,21.50%,1.32M,-1.81M,-2.24M,-0.0960,,5.44M,0.23,2.62M,28.58,1.86,0.34,170.85k,325.78k,Value,130 012,Healthcare,217,"Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.",Changchun,86 431 8554 1826,1199059200,China,86400,509 Maoxiang Street,86 431 8554 1869,Drug Manufacturers—Specialty & Generic,High-Tech Industrial Development Zone
t-3,GBLP,9405532.0,0,170001,,-420300,1141050,-430278,392909,230201,-332709,-332709,,-51588,,,,0,520942,853651,290741,-87591,,-420300,-430278,130119.0,11374300.0,3672763.0,9535651.0,627631.0,14349464.0,2325.0,42911.0,-2518854.0,677880.0,1150318.0,5175169.0,1276225.0,,677880.0,4605424.0,8463603.0,1911128.0,1152145.0,352512.0,2396538.0,52991.0,45009.0,259115.0,310221.0,53482.0,177633.0,70887.0,-248484.0,98253.0,-20400.0,117527.0,-100212.0,-17184.0,-6692.0,51106.0,7187378.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.2591 - 0.2591,0.2591,0.0,0.0,0,0,finmb_20442050,Other OTC,"Global Pharmatech, Inc.",USD,1221,0,0.20899999,4.1716566,0.0501 - 0.4,-0.14090002,-0.35225004,0.0501,0.4,-0.096,USD,4,0.343,0.2363689,0.022731096,0.09616788,0.15947415,0.09962584,0.6247147,1835521,0.75539356,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.2591,1627673631,0.0,0.1732,0.2591,0.2591,14200,GLOBAL PHARMATECH INC,us_market,POST,-4.51,,,0.4,0.0501,0.2364,0.1595,1.22k,,,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2007","Jun 29, 2008",-70.45%,-72.55%,-10.39%,-22.59%,3.18M,0.14,21.50%,1.32M,-1.81M,-2.24M,-0.0960,,5.44M,0.23,2.62M,28.58,1.86,0.34,170.85k,325.78k,Value,130 012,Healthcare,217,"Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.",Changchun,86 431 8554 1826,1199059200,China,86400,509 Maoxiang Street,86 431 8554 1869,Drug Manufacturers—Specialty & Generic,High-Tech Industrial Development Zone
